TorreyPines Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of treatments for diseases and disorders of the central nervous system. It leverages drug targets and technologies to deliver therapies for migraine; chronic pain, including neuropathic pain; and cognitive disorders, including Alzheimer’s disease and schizophrenia. The company’s products in various phases of development include tezampanel (NGX424), an AMPA/kainate receptor antagonist for migraine; NGX426 for migraine and neuropathic pain; and NGX267, NGX292, and NGX555 for Alzheimer’s disease. Its pipeline products also include...
read more
QUOTE
As of 07:48PM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
TPTX |
| SIC: |
-
|
| State location: |
CA |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
13 |
| Type: |
NASDAQ |
TORREYPINES THRP (TPTX) MESSAGE BOARD
| Post # |
Subject |
Re |
Name |
Date |
| There are no comments. |
someone replies to your post?